Showing results (371-380 of 536) with videos related to

Sort By:
Pageof 54
Journal of Virology|January 9, 2015
Stability of structured Kaposi's sarcoma-associated herpesvirus ORF57 protein is regulated by protein phosphorylation and homodimerizationVladimir Majerciak, Natalia Pripuzova, Calvin Chan, et al.
ACS Applied Materials & Interfaces|March 13, 2018
Local Electronic Structure Changes in Polycrystalline CdTe with CdCl2 Treatment and Air ExposureMorgann Berg, Jason M Kephart, Amit Munshi, et al.
The Journal of Hand Surgery|August 17, 2023
Is There a Critical Dorsal Lunate Facet Size in Distal Radius Fractures That Leads to Dorsal Carpal Subluxation? A Biomechanical Study of the Dorsal Critical CornerLauren M Shapiro, Joanne Zhou, Kalpit Shah, et al.
Headache|July 20, 2018
Identifying Natural Subgroups of Migraine Based on Comorbidity and Concomitant Condition Profiles: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) StudyRichard B Lipton, Kristina M Fanning, Dawn C Buse, et al.
The Lancet. Neurology|February 21, 2023
Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trialRichard B Lipton, Robert Croop, David A Stock, et al.
Clinical Neurology and Neurosurgery|August 5, 2021
Multidisciplinary headache clinic-impact of a new model for headache care in DubaiMaria Khan, Abubaker Al Madani, Samah Habboush, et al.
Cephalalgia : an International Journal of Headache|August 14, 2016
Comparative tolerability of treatments for acute migraine: A network meta-analysisKristian Thorlund, Kabirraaj Toor, Ping Wu, et al.
Mayo Clinic Proceedings|October 4, 2011
MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatmentsStewart J Tepper, Shashidhar H Kori, Peter J Goadsby, et al.
Lancet (London, England)|July 18, 2019
Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trialRobert Croop, Peter J Goadsby, David A Stock, et al.
Headache|July 21, 2022
Comparison and predictors of chronic migraine vs. new daily persistent headache presenting with a chronic migraine phenotypeKarthik Nagaraj, Diana Y Wei, Francesca Puledda, et al.
Pageof 54